Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Proceedings of the European Association for the Study of the Liver (EASL) International Consensus Conference on Hepatitis B. September 14-16, 2002. Geneva, Switzerland.

Literature DB >> 14964189

Proceedings of the European Association for the Study of the Liver (EASL) International Consensus Conference on Hepatitis B. September 14-16, 2002. Geneva, Switzerland.

Abstract

Entities: Disease

Mesh：

Year: 2003 PMID： 14964189

Source DB: PubMed Journal: J Hepatol ISSN： 0168-8278 Impact factor: 25.083

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?

Authors: C John Clements; Ben Coghlan; Mick Creati; Stephen Locarnini; Richard S Tedder; Joseph Torresi
Journal: Bull World Health Organ Date: 2009-10-23 Impact factor: 9.408

2. New developments in HBV molecular diagnostics and quantitative serology.

Authors: D Scott Bowden; Alex J Thompson
Journal: Hepatol Int Date: 2008-02-13 Impact factor: 6.047

3. Stability of liver fibrosis among HCV-infected injection drug users.

Authors: Shruti H Mehta; Gregory D Kirk; Jacquie Astemborski; Mark S Sulkowski; Nezam H Afdhal; David L Thomas
Journal: Antivir Ther Date: 2012-03-15

Review 4. Viral hepatitis B: clinical and epidemiological characteristics.

Authors: Gregory S Burns; Alexander J Thompson
Journal: Cold Spring Harb Perspect Med Date: 2014-10-30 Impact factor: 6.915

5. Dynamic coinfection with multiple viral subtypes in acute hepatitis C.

Authors: Jennifer A Smith; Judith H Aberle; Vicki M Fleming; Peter Ferenci; Emma C Thomson; Peter Karayiannis; Angela R McLean; Heidemarie Holzmann; Paul Klenerman
Journal: J Infect Dis Date: 2010-11-10 Impact factor: 5.226

6. Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice.

Authors: Ya-Wen Yang; Bibek Poudel; Julia Frederick; Poonam Dhillon; Rojesh Shrestha; Ziyuan Ma; Junnan Wu; Koji Okamoto; Jeffrey B Kopp; Sheri L Booten; Danielle Gattis; Andrew T Watt; Matthew Palmer; Mariam Aghajan; Katalin Susztak
Journal: Mol Ther Date: 2022-04-20 Impact factor: 12.910

Proceedings of the European Association for the Study of the Liver (EASL) International Consensus Conference on Hepatitis B. September 14-16, 2002. Geneva, Switzerland.

1. Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?

2. New developments in HBV molecular diagnostics and quantitative serology.

3. Stability of liver fibrosis among HCV-infected injection drug users.

Review 4. Viral hepatitis B: clinical and epidemiological characteristics.

5. Dynamic coinfection with multiple viral subtypes in acute hepatitis C.

6. Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice.

7. Intra-voxel incoherent motion MRI in rodent model of diethylnitrosamine-induced liver fibrosis.

8. Exceeding the limits of liver histology markers.

Review 9. Molecular testing in the diagnosis and management of chronic hepatitis B.

10. Evaluation of elevated alanine aminotransferase and hepatitis B virus DNA in healthy seronegative blood donors.